TransMedics TMDX
NASDAQ TMDX
$91.97 -2.00 (-2.13%)
At close: Aug 20, 2026 · 2:36 PM UTC

TransMedics (TMDX) Gains from Investment Securities (2018 - 2019)

TransMedics (TMDX) posted quarterly Gains from Investment Securities of $614000.0 for Q2 2019, up 192.38% year-over-year from $210000.0 in Q2 2018, and up 324.91% quarter-over-quarter from -$273000.0 in Q1 2019.

TransMedics (TMDX) Gains from Investment Securities (2018 - 2019) Analysis & Trends

TransMedics' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $614000.0 for Q2 2019.

  • In Q2 2019, Gains from Investment Securities rose 192.38% year-over-year to $614000.0; the TTM figure through Mar 2020 stood at $614000.0 (up 153.72% YoY), while the FY2022 annual figure was $107000.0, changed N/A from the prior year.
  • Gains from Investment Securities for Q2 2019 stood at $614000.0, up from -$273000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $614000.0 in Q2 2019, with the low at -$273000.0 in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn
10 TransMedics 3.18 Bn 2.71 Bn 113.20 Mn

Historic Data

Download Data
DateValue
Jun 29, 2019 614,000.00
Jun 29, 2019 614,000.00
Mar 30, 2019 -273,000.00
Mar 30, 2019 -273,000.00
Dec 29, 2018 122,000.00
Dec 29, 2018 122,000.00
Sep 29, 2018 183,000.00
Sep 29, 2018 183,000.00
Jun 30, 2018 210,000.00
Jun 30, 2018 210,000.00
Mar 31, 2018 30,000.00
Mar 31, 2018 30,000.00